Chordoma of the skull base: Predictors of tumor recurrence

Journal of Neurosurgery

Volumn 98, Issue 4, 2003, Pages 812-822

  Pallini, Roberto ^a   Maira, Giulio ^b   Pierconti, Francesco ^b   Falchetti, Maria Laura ^b   Alvino, Ester ^b   Cimino Reale, Graziella ^b   Fernandez, Eduardo ^b   D'Ambrosio, Ettore ^b   Larocca, Luigi Maria ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE

Author keywords

Chordoma; Human telomerase reverse transcriptase; P53; Skull base; Tumor recurrence

Indexed keywords

MESSENGER RNA; MICROSATELLITE DNA; PROTEIN P53; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHORDOMA; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKULL BASE TUMOR; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

EID: 0037381276     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.4.0812     Document Type: Article

References (53)

1. Al-Mefty O, Borba LAB: Skull base chordomas: a management challenge. J Neurosurg 86:182-189, 1997
2. Alvino E, Fernandez E, Pallini R: Microsatellite instability in primary brain tumors. Neurol Res 22:571-575, 2000
3. Arnold H, Herrmann HD: Skull base chordoma with cavernous sinus involvement. Partial or radical tumour removal? Acta Neurochir 83:31-37, 1986
4. Benk V, Liebsch NJ, Munzenrider JE, et al: Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 31:577-581, 1995
5. Bergh P, Kindblom LG, Gunterberg B, et al: Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88:2122-2134, 2000
6. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute Workshop on Microsatellite instability for cancer detection and familiar predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257, 1998
7. Borba L, Al-Mefty O, Mrak RE, et al: Cranial chordomas in children and adolescents. J Neurosurg 84:584-591, 1996
8. Buonamici L, Roncaroli F, Fioravanti A, et al: Cytogenetic investigation of chordomas of the skull. Cancer Genet Cytogenet 112: 49-52, 1999
9. Burger PC, Scheithauer BW: Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology, 1994, pp 303-306
10. Butler MG, Dahir GA, Hedges LK, et al: Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas. Cancer Genet Cytogenet 85:51-57, 1995
11. Colli B, Al-Mefty O: Chordomas of the craniocervical junction: follow-up review and prognostic factors. J Neurosurg 95: 933-943, 2001
12. Crockard HA, Steel T, Plowman N, et al: A multidisciplinary team approach to skull base chordomas. J Neurosurg 95:175-183, 2001
13. Dietmaier W, Wallinger S, Bocker T, et al: Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 57:4749-4756, 1997
14. Eisenberg MB, Woloschak M, Sen C, et al: Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas. Surg Neurol 47:156-161, 1997
15. Eshlemann JR, Markowitz SD: Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 7:83-89, 1995
16. Falchetti ML, Pallini R, D'Ambrosio E, et al: In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme. Int J Cancer 88:895-901, 2000
17. Falchetti ML, Pallini R, Larocca LM, et al: Telomerase expression in intracranial tumors: prognostic potential for malignant gliomas and meningiomas. J Clin Pathol 52:234-236, 1999
18. Felsher DW, Bishop JM: Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4:199-207, 1999
19. Fishel R, Lescoe MK, Rao MRS, et al: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038, 1993
20. Flores ER, Tsai KY, Crowley D, et al: p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416:560-564, 2002
21. Forsyth PA, Cascino TL, Shaw EG, et al: Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg 78:741-747, 1993
22. Gay E, Sekhar LN, Rubinstein E, et al: Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 36:887-897, 1995
23. Harada K, Kurisu K, Tahara H, et al: Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker. J Neurosurg 93:618-625, 2000
24. Heffelfinger MJ, Dahlin DC, MacCarty CS, et al: Chordomas and cartilaginous tumors at the skull base. Cancer 32:410-420, 1973
25. Holton JL, Steel T, Luxsuwong M, et al: Skull base chordomas: correlation of tumor doubling time with age, mitosis and Ki67 proliferation index. Neuropathol Appl Neurobiol 26:497-503, 2000
26. Huettner CS, Zhang P, Van Etten RA, et al: Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet 24:57-60, 2000
27. Hug EB, Loredo LN, Slater JD, et al: Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 91:432-439, 1999
28. Klingler L, Shooks J, Fiedler PN, et al: Microsatellite instability in sacral chordoma. J Surg Oncol 73:100-103, 2000
29. Kolquist KA, Ellisen LW, Counter CM, et al: Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 19:182-186, 1998
30. Leach FS, Nicolaides NC, Papadopoulos N, et al: Mutation of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225, 1993
31. Maggiano N, Piantelli M, Ricci R, et al: Detection of growth hormone-producing cells in human thymus by immunohistochemistry and non-radioactive in situ hybridization. J Histochem Cytochem 42:1349-1354, 1994
32. Maira G, Pallini R, Anile C, et al: Surgical treatment of clival chordomas: the transsphenoidal approach revisited. J Neurosurg 85: 784-792, 1996
33. Matsuno A, Sasaki T, Nagashima T, et al: Immunohistochemical examination of proliferative potentials and the expression of cell cycle-related proteins of intracranial chordomas. Hum Pathol 28: 714-719, 1997
34. Menezes AH, Traynelis VC: Tumors of the craniovertebral junction, in Youmans JR (ed): Neurological Surgery: A Comprehensive Reference Guide to the Diagnosis and Management of Neurosurgical Problems, ed 4. Philadelphia: WB Saunders, 1996, Vol 4, pp 3041-3072
35. Mitchell A, Scheithauer BW, Unni K, et al: Chordoma and chondroid tumors of the spheno-occiput: immunohistochemical study of 41 cases. Am J Clin Pathol 98:345, 1992 (Abstract)
36. Mitchell A, Scheithauer BW, Unni KK, et al: Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases whit prognostic and nosologic implications. Cancer 72:2943-2949, 1993
37. Naka T, Fukuda T, Chuman H, et al: Proliferative activities in conventional chordoma: a clinicopathologic, DNA flow cytometric, and immunohistochemical analysis of 17 specimens with special reference to anaplastic chordoma showing a diffuse proliferation and nuclear atypia. Hum Pathol 27:381-387, 1996
38. O'Connel JX, Renard LG, Liebsch NJ, et al: Base of skull chordomas. A correlative study of histologic and clinical features of 62 cases. Cancer 74:2261-2267, 1994
39. Pallini R, Pierconti F, Falchetti ML, et al: Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells. J Neurosurg 94:961-971, 2001
40. Pallini R, Tancredi A, Casalbore P, et al: Neurofibromatosis type 2: growth stimulation of mixed acoustic schwannoma by concurrent adjacent meningioma: possible role of growth factors. Case report. J Neurosurg 89:149-154, 1998
41. Peltomaki P, de la Chapelle A: Mutation predisposing to hereditary nonpolyposis colorectal cancer. Adv Cancer Res 71:93-119, 1997
42. Raffel C, Wright DC, Gutin PH, et al: Cranial chordomas: clinical presentation and result of operative and radiation therapy in twenty-six patients. Neurosurgery 17:703-710, 1985
43. Rich TA, Schiller A, Suit HD, et al: Clinical and pathologic review of 48 cases of chordoma. Cancer 56:182-187, 1985
44. Schoedel K, Martinez AJ, Mahoney TM, et al: Chordomas: pathological features, ploidy and silver nucleolar organizing region analysis. A study of 36 cases. Acta Neuropathol 89:139-143, 1995
45. Sekhar LN, Gay E, Wright DC: Chordomas and chondrosarcomas of the cranial base, in Wilkins RH, Rengachary SS (eds): Neurosurgery, ed 2. New York: McGraw-Hill, 1996, Vol 2, pp 1529-1543
46. Sen CN, Sekhar LN, Schramm VL, et al: Chordoma and chondrosarcoma of the cranial base: an 8-year experience. Neurosurgery 25:931-941, 1989
47. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791, 1997
48. Thibodeau SN, Bren G, Shaid D: Microsatellite instability in cancer of the proximal colon. Science 260:816-819, 1993
49. Tomlinson FH, Scheithauer BW, Forsythe PA, et al: Sarcomatous transformation in cranial chordoma. Neurosurgery 31:13-18, 1992
50. Vojtesek B, Bartek J, Midgley CA, et al: An immunochemical analysis of the human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151:237-244, 1992
51. Watkins L, Khudados ES, Kaleoglu M, et al: Skull base chordomas: a review of 38 patients, 1958-88. Br J Neurosurg 7: 241-248, 1993
52. Wold LE, Laws ER Jr: Cranial chordomas in children and young adults. J Neurosurg 59:1043-1047, 1983
53. Zambetti GP, Levine AJ: A comparison of the biological activities of wild-type and mutant p53. FASEB J 7:855-865, 1993